Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
2. Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H (2020) Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: revision working position paper. Int J Urol 27:362–368. https://doi.org/10.1111/iju.14210
3. EAU Guidelines (2023) Edn Presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6
4. Chang SS, Boorjian SA, Chou R, Clark PE, Siamak D, Konety BR et al (2016) Non-muscle invasive bladder cancer: American urological association/SUO guideline. https://www.auanet.org/education/guidelines/non-muscle-invasive-bladder-cancer.cfm
5. Schroeck FR, Smith N, Shelton JB (2018) Implementing risk-aligned bladder cancer surveillance care. Urol Oncol 36:257–264. https://doi.org/10.1016/j.urolonc.2017.12.016